Kelly was 26 weeks pregnant when she started to experience seizures along the left side of her body. After meeting with several doctors, she learned her symptoms started from a skin cancer. “I was diagnosed with stage IV melanoma in my armpit that had spread to my brain and was a serious threat to me and my unborn child,” says Kelly.
One of the top search phrases on SkinCancer.org is, “Can I leave my skin cancer alone?” Two of our physician experts answer why, when you’ve been diagnosed with a skin cancer, time is of the essence.
Q: Recent reports show that male deaths due to skin cancer are increasing around the world. What do you think is going on, and how can we help men fare better?
What is this new treatment, and why is it such a big step forward?
A tanning bed will never provide you with the vitamin D that you need, nor is it safer than tanning outdoors. Not understanding the facts can literally mean the difference between life and death.
If you (or someone you know) has been diagnosed with two or more nonmelanoma skin cancers, you are part of a special group. You are also, unfortunately, at much higher risk of developing further skin cancers.
While physicians commonly use Mohs surgery or excisional surgery to remove skin cancer, additional steps may be required to fully reconstruct the surgical site. One way physicians close a surgical area is by using surrounding tissue, also called flap surgery.
Most people don’t apply enough sunscreen, which is why undesirable sunburns and tanning can occur despite sunscreen application.
All melanomas are associated with an initial tumor, but sometimes the location is difficult to ascertain.
You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.